These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Acute lymphoblastic leukemia: current status of therapy in children. Lampert F; Henze G; Langermann HJ; Schellong G; Gadner H; Riehm HJ Recent Results Cancer Res; 1984; 93():159-81. PubMed ID: 6382478 [No Abstract] [Full Text] [Related]
6. Association of delivered drug dose and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features. Gaynon PS; Steinherz PG; Bleyer WA; Finklestein JZ; Miller DR; Reaman GH; Sather HN; Hammond GD Med Pediatr Oncol; 1991; 19(4):221-7. PubMed ID: 2056967 [TBL] [Abstract][Full Text] [Related]
7. The BFM relapse studies in childhood ALL: concepts of two multicenter trials and results after 2 1/2 years. Henze G; Buchmann S; Fengler R; Hartmann R Haematol Blood Transfus; 1987; 30():147-55. PubMed ID: 3305191 [No Abstract] [Full Text] [Related]
8. [Factors influencing the prognosis of lymphoblastic leukemia in children]. Vargas L; Barría M; Young T; Pino S; García H Rev Chil Pediatr; 1984; 55(3):156-63. PubMed ID: 6594727 [No Abstract] [Full Text] [Related]
11. [Consolidating chemotherapy in the treatment program of acute lymphoblastic leukemia in children]. Maiakova SA; Makhonova LA Vestn Akad Med Nauk SSSR; 1986; (5):15-7. PubMed ID: 3487897 [No Abstract] [Full Text] [Related]
12. Clinical experiences with a modified BFM protocol in childhood acute lymphoblastic leukemia. Zintl F; Malke H; Plenert W Haematol Blood Transfus; 1985; 29():84-9. PubMed ID: 3896979 [No Abstract] [Full Text] [Related]
13. [Therapeutic study VII/81 of the treatment of acute lymphoblastic leukemia in childhood]. Zintl F; Plenert W; Malke H; Blau HJ; Dörffel W; Exadaktylos P; Hofmann K; Korth G; Kotte W; Kuhnert W Kinderarztl Prax; 1986 Mar; 54(3):141-52. PubMed ID: 3520095 [No Abstract] [Full Text] [Related]
14. Stratification by prognostic factors in the design and analysis of clinical trials for acute lymphoblastic leukemia. Hammond GD; Sather H; Bleyer WA; Coccia P Haematol Blood Transfus; 1987; 30():161-6. PubMed ID: 3305192 [No Abstract] [Full Text] [Related]
15. Monoclonal-antibody-purged autologous bone marrow transplantation for relapsed non-T-cell acute lymphoblastic leukemia in childhood. Niemeyer CM; Ritz J; Donahue K; Sallan SE Haematol Blood Transfus; 1987; 31():67-74. PubMed ID: 2965082 [No Abstract] [Full Text] [Related]
16. Therapy results in five ALL-BFM studies since 1970: implications of risk factors for prognosis. Riehm H; Feickert HJ; Schrappe M; Henze G; Schellong G Haematol Blood Transfus; 1987; 30():139-46. PubMed ID: 3476353 [No Abstract] [Full Text] [Related]
17. Recent results from Total Therapy Study X for standard and high risk acute lymphoblastic leukemia in children: recognition of new clinical and biologic risk features. Murphy SB; Dahl GV; Look AT; Ochs J; Abromowitch M; Pui CH; Bowman WP; Simone JV; Kalwinsky DK; Evans WE Haematol Blood Transfus; 1985; 29():78-81. PubMed ID: 3861494 [No Abstract] [Full Text] [Related]
18. [Evaluation of two methods of maintenance chemotherapy with methotrexate and 6-mercaptopurine for childhood acute lymphoblastic leukemia]. Kawai S; Fujimoto T; Hiyoshi Y; Nibu K; Ito M; Kadoya S; Shingaki Y Rinsho Ketsueki; 1984 Jun; 25(6):819-26. PubMed ID: 6384569 [No Abstract] [Full Text] [Related]
19. Two unexpected courses in four children with lymphoblastic leukemia of B-cell type (B-ALL). Kühl J; Kreth HW Haematol Blood Transfus; 1987; 30():432-6. PubMed ID: 3497847 [No Abstract] [Full Text] [Related]